HKI-272 for HER2-Positive Breast Cancer and Brain Metastases

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by Dana-Farber Cancer Institute
Sponsor:
Collaborator:
Translational Breast Cancer Research Consortium
Information provided by (Responsible Party):
Rachel Freedman, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01494662
First received: December 14, 2011
Last updated: January 28, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)